When and How Do I Use Neoadjuvant Chemotherapy for Breast Cancer?

Author： Rapoport Bernardo   Demetriou Georgia   Moodley Shun   Benn Carol  

Publisher： Springer Publishing Company

ISSN： 1527-2729

Source： Current Treatment Options in Oncology, Vol.15, Iss.1, 2014-03, pp. : 86-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

By Straver M.  

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2411-2418

Springer Publishing Company

Access to resources Recommend Favorite

Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy

By Fuksa L.   Micuda S.   Grim J.   Ryska A.   Hornychova H.  

Cancer Investigation, Vol. 30, Iss. 9, 2012-10 ,pp. : 663-678

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?

By Braud A.C.   Asselain B.   Scholl S.   De La Rochefordiere   Palangie T.   Dieras V.   Pierga J.Y.   Dorval T.   Jouve M.   Beuzeboc P.   Pouillart P.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

The surgical management of patients following neoadjuvant chemotherapy for locally advanced breast cancer

By Sauven P.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2371-2374

Elsevier

Access to resources Recommend Favorite

Neo-adjuvant chemotherapy for operable breast cancer induces apoptosis

By Shao Z-m.  

Breast Cancer Research and Treatment, Vol. 53, Iss. 3, 1999-02 ,pp. : 263-269

Springer Publishing Company

Access to resources Recommend Favorite